Enhanced antibacterial and anti-inflammatory properties of Hwangryeonhaedok-tang fermented with Kimchi-derived Lactiplantibacillus plantarum WiKim0111 for potential acne treatment
- PMID: 40549336
- PMCID: PMC12350970
- DOI: 10.1007/s42770-025-01703-z
Enhanced antibacterial and anti-inflammatory properties of Hwangryeonhaedok-tang fermented with Kimchi-derived Lactiplantibacillus plantarum WiKim0111 for potential acne treatment
Abstract
Recent years have seen an increase in the incidence of acne in adults and teenagers resulting in active research in acne treatment. In the present study, we aimed to improve the anti-acne effects of Hwangryeonhaedok-tang (HHT) through fermentation using a kimchi-derived lactic acid bacterium. Lactiplantibacillus plantarum WiKim0111 (Lpb. plantarum WiKim0111) was selected to ferment HHT due to its strong antioxidant activity and its ability to effectively survive and grow in the HHT medium. The antimicrobial activity of HHT and fermented HHT (FHHT) against Cutibacterium acnes (C. acnes) was determined using an agar well diffusion assay. FHHT exhibited stronger antimicrobial, radical scavenging, and superoxide dismutase activity compared to HHT. RAW 264.7 cells pretreated HHT or FHHT showed significantly lower production of nitric oxide, interleukin (IL) -1β, and IL-6 than lipopolysaccharide -treated cells, with FHHT demonstrating higher efficiency than HHT. Overall, HHT fermented by Lpb. plantarum WiKim0111 displayed enhanced antioxidant and anti-inflammatory properties, as well as greater antibacterial activity against C. acnes compared to unfermented HHT. These findings suggest that FHHT may help mitigate acne symptoms by reducing oxidative stress, modulating inflammation, and directly inhibiting the growth of C. acnes. Further in vitro studies focusing on sebum-producing skin cells, as well as clinical trials evaluating the topical or oral application of FHHT, would be valuable to confirm its efficacy and safety in acne treatment.
Keywords: Lactiplantibacillus plantarum; Anti-acne effect; Anti-bacterial agents; Anti-inflammatory agents; Fermentation; Hwangryunhaedok-tang.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare that they have no Competing interests.
Figures






Similar articles
-
Polyherbal Antiacne Gel: In Vitro Antibacterial Activity and Efficacy Evaluation Against Cutibacterium acnes.Assay Drug Dev Technol. 2024 Oct;22(7):373-386. doi: 10.1089/adt.2024.031. Epub 2024 Sep 10. Assay Drug Dev Technol. 2024. PMID: 39253845
-
Identification of Protocatechuic acid as an anti-acne component in extracts of black rice bran.Sci Rep. 2025 Jul 1;15(1):21151. doi: 10.1038/s41598-025-07396-6. Sci Rep. 2025. PMID: 40595175 Free PMC article.
-
Minocycline for acne vulgaris: efficacy and safety.Cochrane Database Syst Rev. 2003;(1):CD002086. doi: 10.1002/14651858.CD002086. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002086. doi: 10.1002/14651858.CD002086.pub2. PMID: 12535427 Updated.
-
Temporin-GHa derived peptide shows inhibitory efficacy against Cutibacterium acnes and alleviates inflammatory reactions in acne vulgaris.Int Immunopharmacol. 2025 Jun 5;157:114756. doi: 10.1016/j.intimp.2025.114756. Epub 2025 May 2. Int Immunopharmacol. 2025. PMID: 40318277
-
Minocycline for acne vulgaris: efficacy and safety.Cochrane Database Syst Rev. 2000;(2):CD002086. doi: 10.1002/14651858.CD002086. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2003;(1):CD002086. doi: 10.1002/14651858.CD002086. PMID: 10796856 Updated.
References
-
- Da Cunha MG, Fonseca FLA, Machado CDAS (2013) Androgenic hormone profile of adult women with acne. Dermatol 226(2):167–171. 10.1159/000347196 - PubMed
-
- Dréno B, Pécastaings S, Corvec S, Veraldi S, Khammari A, Roques C (2018) Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates. JEADV 32:5–14. 10.1111/jdv.15043 - PubMed
-
- Melnik BC (2018) Acne vulgaris: the metabolic syndrome of the pilosebaceous follicle. Clin Dermatol 36(1):29–40. 10.1016/j.clindermatol.2017.09.006 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical